Mass. doctor leads new type of cell therapy offering hope to lupus patients
CAR-T cell therapy, a marvel of bioengineering, takes a patient’s own immune cells and reprograms them to attack cells causing Lupus. First approved for treating leukemia in 2017, CAR-T cell therapy ...
Hosted on MSN35m
Researchers Discover Key Factor Behind Disease Resistance in Gene Carriers
New work by Columbia researchers has turned a textbook principle of genetics on its head and revealed why some people who ...